Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Aerosolized Monkeypox Virus

SN Shchelkunov, 2001, Human monkeypox and smallpox viruses: genomic comparison., FEBS Lett, 509, 66, 10.1016/S0014-5793(01)03144-1

S Parker, 2007, Human monkeypox: an emerging zoonotic disease., Future Microbiol, 2, 17, 10.2217/17460913.2.1.17

A Nalca, 2005, Reemergence of monkeypox: prevalence, diagnostics, and countermeasures., Clin Infect Dis, 41, 1765, 10.1086/498155

Z Jezek, 1988, Human monkeypox.

PE Fine, 1988, The transmission potential of monkeypox virus in human populations., Int J Epidemiol, 17, 643, 10.1093/ije/17.3.643

KA Marriott, 2008, Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge., Vaccine, 26, 581, 10.1016/j.vaccine.2007.10.063

PL Earl, 2004, Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox., Nature, 428, 182, 10.1038/nature02331

PL Earl, 2008, Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus., Proc Natl Acad Sci U S A, 105, 10889, 10.1073/pnas.0804985105

Y Edghill-Smith, 2005, Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus., Nat Med, 11, 740, 10.1038/nm1261

L Handley, 2009, The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks., Expert Rev Vaccines, 8, 841, 10.1586/erv.09.55

P Nigam, 2007, DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge., Virology, 366, 73, 10.1016/j.virol.2007.04.010

NL Garza, 2009, Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model., Vaccine, 27, 5496, 10.1016/j.vaccine.2009.06.105

2002, New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible., 21 CFR Parts 314 and 601

M Kramski, A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection., PLoS One, 5, e10412, 10.1371/journal.pone.0010412

MM Adams, 2007, Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox., J Virol, 81, 11084, 10.1128/JVI.00423-07

J Huggins, 2009, Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246., Antimicrob Agents Chemother, 53, 2620, 10.1128/AAC.00021-09

CL Hutson, 2009, A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus., J Gen Virol, 90, 323, 10.1099/vir.0.005108-0

J Schriewer, 2004, Mouse models for studying orthopoxvirus respiratory infections., Methods Mol Biol, 269, 289

DF Smee, 2008, Progress in the discovery of compounds inhibiting orthopoxviruses in animal models., Antivir Chem Chemother, 19, 115, 10.1177/095632020801900302

KJ Stittelaar, 2006, Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection., Nature, 439, 745, 10.1038/nature04295

RB Tesh, 2004, Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus., Emerg Infect Dis, 10, 1563, 10.3201/eid1009.040310

DA Henderson, 2009, Smallpox: the death of a disease: the inside story of eradicating a worldwide killer.

JR Swearengen, 2006, Biodefense: research methodology and animal models.

PB Jahrling, 2004, Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox., Proc Natl Acad Sci U S A, 101, 15196, 10.1073/pnas.0405954101

GM Zaucha, 2001, The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis)., Lab Invest, 81, 1581, 10.1038/labinvest.3780373

TK Besch, 1996, Steady-state minute volume determination by body-only plethysmography in juvenile rhesus monkeys., Lab Anim Sci, 46, 539

JM Hartings, 2004, The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates., J Pharmacol Toxicol Methods, 49, 39, 10.1016/j.vascn.2003.07.001

A Nalca, 2008, Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model., Antiviral Res, 79, 121, 10.1016/j.antiviral.2008.03.005

EB Prophet, 1992, Laboratory Methods for Histotechnology.

KD Bauer, 2000, Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging., Clin Cancer Res, 6, 3552

MG Reynolds, 2006, Clinical manifestations of human monkeypox influenced by route of infection., J Infect Dis, 194, 773, 10.1086/505880

N Hahon, 1961, Smallpox and related poxvirus infections in the simian host., Bacteriol Rev, 25, 459, 10.1128/MMBR.25.4.459-476.1961

R Jordan, 2009, ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification., Antimicrob Agents Chemother, 53, 1817, 10.1128/AAC.01596-08

KJ Stittelaar, 2005, Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus., J Virol, 79, 7845, 10.1128/JVI.79.12.7845-7851.2005

AW Rimoin, 2007, Endemic human monkeypox, Democratic Republic of Congo, 2001-2004., Emerg Infect Dis, 13, 934, 10.3201/eid1306.061540

YJ Hutin, 2001, Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997., Emerg Infect Dis, 7, 434, 10.3201/eid0703.017311

N Hahon, 1961, Air-borne infectivity of the variola-vaccinia group of poxviruses for the cynomolgus monkey, Macaca irus., J Infect Dis, 109, 294, 10.1093/infdis/109.3.294

GD Huhn, 2005, Clinical characteristics of human monkeypox, and risk factors for severe disease., Clin Infect Dis, 41, 1742, 10.1086/498115

CL Hutson, Comparison of West African and Congo Basin monkeypox viruses in BALB/c and C57BL/6 mice., PLoS One, 5, e8912, 10.1371/journal.pone.0008912